Filing Details
- Accession Number:
- 0001203311-13-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-11 19:00:58
- Reporting Period:
- 2013-09-10
- Filing Date:
- 2013-09-11
- Accepted Time:
- 2013-09-11 19:00:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202785 | Eric Dobmeier | 21823 30Th Drive Se Bothell WA 98021 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-10 | 20,312 | $20.52 | 156,155 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-10 | 20,312 | $46.40 | 135,843 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-09-10 | 3,859 | $15.46 | 139,702 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-10 | 3,859 | $46.40 | 135,843 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-09-10 | 15,829 | $26.10 | 151,672 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-10 | 15,829 | $46.40 | 135,843 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-10 | 2,000 | $46.45 | 133,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 3,859 | $0.00 | 3,859 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 20,312 | $0.00 | 20,312 | $20.52 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 15,829 | $0.00 | 15,829 | $26.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 43,089 | 2021-08-24 | No | 4 | M | Direct | |
| 12,500 | 2021-06-30 | No | 4 | M | Direct | |
| 45,340 | 2022-08-20 | No | 4 | M | Direct |
Footnotes
- Amount of Securities beneficially owned following reported transactions includes 61,334 Restricted Stock Units subject to vesting.
- $46.4015 represents an average price per share for the shares sold on 9/10/2013. The sell price for shares sold on this day ranged from $46.20 to $46.70.
- Shares shall vest at a rate of 25% on 8/24/12 and monthly thereafter until all the shares are fully vested on 8/24/15.
- Shares shall vest at a rate of 25% on 6/30/2012 and monthly thereafter until all the shares are fully vested on 6/30/15.
- Shares shall vest at a rate of 25% on August 20, 2013 and monthly thereafter until all the shares are fully vested on August 20, 2016.
Billionaire Hedge Funds
